AMCP Market Insights: The role of managed care in improving patient care in mucopolysaccharidoses. [PDF]
Flavin B +8 more
europepmc +1 more source
MUSCULOSKELETAL ALTERATIONS OF ORTHOPEDIC INTEREST IN MUCOPOLYSACCHARIDOSES. [PDF]
Matos MA, Lopes PS.
europepmc +1 more source
Guidance for Home Enzyme Replacement Therapy in Children and Adolescents Diagnosed with Mucopolysaccharidoses: A Scoping Review Protocol. [PDF]
Oliveira VR +5 more
europepmc +1 more source
Orofacial manifestations in mucopolysaccharidoses: a comprehensive clinical and radiographic evaluation of 35 pediatric cases. [PDF]
Çoğulu D +5 more
europepmc +1 more source
Commentary: Lysosomal enzymes engineered to cross the blood-brain barrier are reshaping the therapeutic landscape of neuronopathic mucopolysaccharidoses. [PDF]
Sorrentino NC, Fraldi A.
europepmc +1 more source
Retinal microstructual and microvascular changes in mucopolysaccharidoses. [PDF]
Wipprecht L +8 more
europepmc +1 more source
Growth Patterns in MPS IVA and MPS IIIA: A Longitudinal Single-Center Study. [PDF]
Carmon L +9 more
europepmc +1 more source
Mucopolysaccharidoses: A biochemical study under limited resources. [PDF]
Bouzid F +7 more
europepmc +1 more source
Quantification of glycosaminoglycans in dried blood spots, and evaluation of its usefulness as a secondary newborn screening test for mucopolysaccharidoses. [PDF]
Oboshi W +27 more
europepmc +1 more source

